The companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.

Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...

An Antidiabetic Helps the Immune System Recognize Reservoirs of HIV Sep. 10, 2024 — Metformin, a drug used to treat type 2 diabetes, could help deplete the viral reservoir and eliminate it ...

Historically, as mentioned, PrEP has been used to treat cisgender gay men, especially in light of the HIV crisis of the 1980s ...

Namibia has made significant strides in stemming the spread of HIV and AIDS through education and prevention. However, for ...

It is just as safe and effective for people with HIV in need of kidney transplantation to get their organ from donors who are ...

Alchemy, which sets up pharmacies in community clinics, said that it had raised $31 million from Andreessen Horowitz and ...

The executive director of Regional HIV/AIDS Connection, which operates Carepoint, the city’s supervised drug-use site, said ...

Oklahoma legalized needle exchange programs three years ago. Since then, over half a million clean syringes have been ...

Moderate and high SUD risk was significantly increased among people living with HIV during the COVID-19 pandemic, between 2018 and 2022.

EDP-323 is an investigational inhibitor of Respiratory Syncytial Virus (RSV), currently showing promising results in Phase 2a ...

Post-exposure prophylaxis (PEP) is a preventative medicine taken after a possible exposure to HIV, such as from a needlestick or sexual assault. ART is a combination of medications used to treat HIV.